---
title: Samsung Biologics vs Sophia CDMO
slug_a: samsungbiologics
slug_b: sophiacdmo
site: cdmo
review_signal_gate: closed
canonical_path: /compare/samsungbiologics/sophiacdmo
generated_by: BioBM Editorial AI
---

# Samsung Biologics vs Sophia CDMO

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Samsung Biologics (samsungbiologics) is listed for cdmo. Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.

Services: 23. Modalities: 5. Indications: 1. Locations: 8. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (23).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Sophia CDMO (sophiacdmo) is listed for cdmo. European CDMO specializing in microbial and precision fermentation up to 40,000 L across two integrated sites (Pamplona, Spain and Basel, Switzerland), with core strengths in E. coli expression, animal health biologics, probiotics, and complex CMC programs requiring scale-up discipline and impurity control.

Services: 18. Modalities: 5. Indications: 0. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (18).

Review summary: Review summary withheld until site-level review gate opens.